会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 70. 发明授权
    • Heterocyclic amines having central nervous system activity
    • 具有中枢神经系统活性的杂环胺
    • US5273975A
    • 1993-12-28
    • US778204
    • 1991-12-06
    • Malcolm W. MoonRichard F. HeierJeanette K. Morris
    • Malcolm W. MoonRichard F. HeierJeanette K. Morris
    • C07D215/40C07D455/04C07D471/06C07D498/06C07D513/06A61K31/495A61K31/50C07D513/02
    • C07D471/06C07D215/40C07D455/04C07D513/06
    • Tricyclic nitrogen containing compounds, having central nervous system activity of the following structural formula: ##STR1## and pharmaceutically acceptable salts thereof wherein R.sub.1, R.sub.2, and R.sub.3 are independently hydrogen, C.sub.1-6 alkyl, alkenyl, or alkynyl, C.sub.3-10 cycloalkyl, or R.sub.1 and R.sub.2 are joined to form a C.sub.3-7 cyclic amine which can contain additional heteroatoms; X is hydrogen, C.sub.1-6 alkyl halogen, hydroxy, alkoxy, cyano, carboxamide, carboxyl, or carboalkoxyl; A is SO.sub.2, N, CH, CH.sub.2, CHCH.sub.3, C.dbd.O, C.dbd.S, C-SCH.sub.3, C.dbd.NH, C-NH.sub.2, C-NHCH.sub.3, C--NHCOOCH.sub.3, or C--NHCN. B is CH.sub.2, CH, C.dbd.O, N, NH or N--CH.sub.3 ; n is 0 or 1; and D is CH, CH.sub.2, C.dbd.O, O, N, NH or N--CH.sub.3. These new compounds are suitable for treating schizophrenia, Parkinson's disease, anxiety, depression or as compounds for lowering blood pressure in animal or human hosts.
    • PCT No.PCT / US90 / 02621 Sec。 371 1991年12月6日第 102(e)1990年12月6日授权PCT 1990年5月15日提交PCT。具有以下结构式的中枢神经系统活性的三环氮化合物:其中R1,R2和R3独立地为 氢,C 1-6烷基,烯基或炔基,C 3-10环烷基或R 1和R 2连接形成可含有其它杂原子的C 3-7环胺; X是氢,C 1-6烷基卤素,羟基,烷氧基,氰基,羧酰胺,羧基或烷氧羰基; A是SO 2,N,CH,CH 2,CHCH 3,C = O,C = S,C-SCH 3,C = NH,C-NH 2,C-NHCH 3,C-NHCOOCH 3或C-NHCN。 B是CH 2,CH,C = O,N,NH或N-CH 3; n为0或1; 且D为CH,CH 2,C = O,O,N,NH或N-CH 3。 这些新化合物适用于治疗精神分裂症,帕金森病,焦虑症,抑郁症或作为降低动物或人类宿主血压的化合物。